This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology  • Breast Cancer  • Women's Health  • Women's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The recent article by Eliassen et al¹ found no breast cancer risk reduction among statin users from the Nurses Health Study (n = 75 828). However, there is inadequate data on type of statin use—lipophobic statins have been shown to have little effect on cancer growth in vitro or in vivo and should not be included in the analysis.² Furthermore, dose-duration effects were not considered, and data were based on self-reporting.

Mortimer et al³ (n = 68 071) found a significant reduction in breast cancers among women older than 50 years, conferred by lipophilic statin use. Kochhar et al⁴ (n = 40 421) similarly showed a protective benefit among lipophilic statin users (relative risk = 0.49), increasing with longer duration of use (relative risk = 0.38, use >4 years).

Eliassen et al¹ also found no association among statin use and histologic subtype of the tumor, contrary to findings we will present at the San Antonio Breast Cancer Symposium. Breast cancers arising in patients . . . [Full Text of this Article]

AUTHOR INFORMATION
Anjali S. Kumar, MD, MPH; Christopher C. Benz, MD; Laura J. Esserman, MD, MBA

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Serum Lipids, Lipid-Lowering Drugs, and the Risk of Breast Cancer
A. Heather Eliassen, Graham A. Colditz, Bernard Rosner, Walter C. Willett, and Susan E. Hankinson
Arch Intern Med. 2005;165(19):2264-2271.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Estrogen Receptor-Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users
Kumar et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:1028-1033.
ABSTRACT | FULL TEXT  

Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey
Hall et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1587-1594.
ABSTRACT | FULL TEXT